Home » Gottlieb Hears From Lawmakers on Drug Compounding
Gottlieb Hears From Lawmakers on Drug Compounding
FDA Commissioner Scott Gottlieb is getting pressure from Capitol Hill to change official FDA guidance for compounders.
A bipartisan group of 65 lawmakers sent a letter pressing him to rescind a late 2016 agency decision restricting state-licensed pharmacies from compounding prescription drugs for healthcare providers to use in their offices without an individual prescription.
Instead, the letter calls on the agency to draft a proposed rule allowing office-use compounding where authorized by state law.
Led by Reps. Chris Stewart (R-Utah) and Earl L. “Buddy” Carter (R-Ga.), the coalition is arguing that the FDA guidance goes against Congressional intent.
Upcoming Events
-
07May
-
14May
-
30May